Glycogen synthase kinase 3 beta (GSK3β) is a serine/threonine kinase that has an important role in several biochemical processes and diseases. It consists of an N-terminal domain rich in β-strands and a C-terminal α-helical domain. As part of the biomolecular condensate of the β-catenin destruction complex, GSK3β participates in both positive and negative regulation of the Wnt signalling pathway. In the absence of signaling with Wnt ligands GSK3β hyperphosphorylates β-catenin and marks it for ubiquitination and proteasomal degradation.
As part of the diploma thesis, we wanted to express and isolate human recombinant GSK3β in order to better understand its role and interactions with the proteins of the β-catenin destruction complex. We wanted to express GSK3β in E. coli strain BL21[DE3]. The gene for GSK3β was inserted into the pET32b(+) vector and fused at the 5’ end with a sequence for the hexahistidine tag, followed by gene for sfGFP. The hexahistidine tag and sfGFP could be cleaved by TEV protease. In the following, we expressed the genes and tried to isolate GSK3β by nickel affinity chromatography.
The process of protein expression and isolation did not turn out to be optimal, since endogenous proteases most likely cleaved GSK3β during expression. We found out that when pRARE plasmid, which has genes for some tRNAs that are rare in E. coli, was included in protocol, GSK3β was less expressed in E. coli strain BL21[DE3]. For more successful expression and isolation of the recombinant human GSK3β, we could try to express the protein with the addition of inhibitors of endogenous proteases in E. coli.
|